The purpose of this study is to examine the effect of financial burden, using objective and subjective indicators, on the health-related quality of life (HRQOL) in lung cancer patients.
A total of 227 patients diagnosed with lung cancer (from the inpatient unit of the department of internal medicine-chest oncology, in Shanghai Chest Hospital, China) participated in the study. Financial information was measured by direct medical costs, direct nonmedical costs, healthcare-cost-to-income ratio, and perceived financial difficulty. HRQOL was measured using the Functional Assessment of Cancer Therapy-Lung (FACT-L) scale.
Catastrophic health spending, defined as a healthcare-cost-to-income ratio of more than 40%, was reported in 72.7% of the participants, whereas 37.0% reported that healthcare costs exceeded annual household income. Financial difficulty was perceived in 83.7% of the participants. Patients whose healthcare costs exceeded their annual household income and who perceived financial difficulty reported a clinically meaningful difference in overall HRQOL (> 6 points on the FACT-L) compared with participants without catastrophic health spending or perceived financial difficulty. Healthcare costs did not show a significant effect on HRQOL.
Healthcare costs exceeding total annual household income and perceived financial difficulty are associated with poorer HRQOL in lung cancer patients. Subjective indicator of financial burden has a stronger effect on quality of life than objective indicators.
Health-cost-to-income ratio and perceived financial difficulty can be implied as objective and subjective indicators of financial burden to identify the patients who may need additional assistance. Communication on deciding on cost-effective treatments can be facilitated.
This is a preview of subscription content, log in to check access.
Buy single article
Instant unlimited access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Chen WQ, Zheng RS, Baade PD et al (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66(2):115–132
van der Linden N, Bongers ML, Coupe VMH et al (2016) Costs of non-small cell lung cancer in the Netherlands. Lung Cancer 91:79–88
Zeng XH, Kamon J, Wang SY et al (2012) The cost of treating advanced non-small cell lung cancer: estimates from the Chinese experience. PLoS One 7(10):e48323
Polanski J, Jankowska-Polanska B, Rosinczuk J et al (2016) Quality of life of patients with lung cancer. Onco Targets Ther 9:1023–1028
Zarogoulidou V, Panagopoulou E, Papakosta D et al (2015) Estimating the direct and indirect costs of lung cancer: a prospective analysis in a Greek University Pulmonary Department. J Thorac Dis 7:S12–S19
Gupta D, Lis CG, Grutsch JF (2007) Perceived cancer-related financial difficulty: implications for patient satisfaction with quality of life in advanced cancer. Support Care Cancer 15(9):1051–1056
Delgado-Guay M, Ferrer J, Rieber AG et al (2015) Financial distress and its associations with physical and emotional symptoms and quality of life among advanced cancer patients. Oncologist 20(9):1092–1098
Lathan CS, Cronin A, Tucker-Seeley R et al (2016) Association of financial strain with symptom burden and quality of life for patients with lung or colorectal cancer. J Clin Oncol 34(15):1732–1740
Zafar SY, McNeil RB, Thomas CM et al (2015) Population-based assessment of cancer survivors’ financial burden and quality of life: a prospective cohort study. J Oncol Pract 11(2):145–U472
Choi JW, Park EC, Yoo KS et al (2015) The effect of high medical expenses on household income in South Korea: a longitudinal study using propensity score matching. BMC Health Serv Res 15:369
Kim Y, Yang B (2011) Relationship between catastrophic health expenditures and household incomes and expenditure patterns in South Korea. Health Policy 100(2–3):239–246
Xu K, Evans DB, Kawabata K et al (2003) Household catastrophic health expenditure: a multicountry analysis. Lancet 362(9378):111–117
Sharp L, Carsin AE, Timmons A (2013) Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer. Psycho-Oncology 22(4):745–755
Perrone F, Jommi C, Di Maio M et al (2016) The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy. Ann Oncol 27(12):2224–2229
Azzani M, Roslani AC, Su TT (2016) Financial burden of colorectal cancer treatment among patients and their families in a middle-income country. Support Care Cancer 24(10):4423–4432
Kodama Y, Morozumi R, Matsumura T et al (2012) Increased financial burden among patients with chronic myelogenous leukaemia receiving imatinib in Japan: a retrospective survey. BMC Cancer 12:152
Zaidi AA, Ansari TZ, Khan A (2012) The financial burden of cancer: estimates from patients undergoing cancer care in a tertiary care hospital. Int J Equity Health 11(1):60
Choi Y, Kim JH, Park EC (2015) The effect of subjective and objective social class on health-related quality of life: new paradigm using longitudinal analysis. Health Qual Life Outcomes 13:121
Singh-Manoux A, Marmot MG, Adler NE (2005) Does subjective social status predict health and change in health status better than objective status? Psychosom Med 67(6):855–861
Honjo K, Kawakami N, Tsuchiya M et al (2014) Association of subjective and objective socioeconomic status with subjective mental health and mental disorders among Japanese men and women. Int J Behav Med 21(3):421–429
Cella DF, Bonomi AE, Lloyd SR et al (1995) Reliability and validity of the functional assessment of cancer therapy-lung (FACT-L) quality-of-life instrument. Lung Cancer 12(3):199–220
Huang HY, Shi JF, Guo LW et al (2016) Expenditure and financial burden for common cancers in China: a hospital-based multicentre cross-sectional study. Lancet 388:S10
Markman M, Luce R (2010) Impact of the cost of cancer treatment: an internet-based survey. J Oncol Pract 6(2):69–73
Sun YL, Gregersen H, Yuan W (2016) Chinese health care system and clinical epidemiology. Clin Epidemiol 9:167–178
World Health Organization. Out-of-pocket expenditure on health as a percentage total expenditure on health (%): 2014. Available from URL: http://gamapserver.who.int/gho/interactive_charts/health_financing/atlas.html?indicator=i5. [accessed September 30, 2016]
Zhang X, Liu SA, Liu Y, et al. Economic burden for lung cancer survivors in urban China. Int J Environ Res Public Health 2017;14. http://doi.org/10.3390/ijerph14030308
Cella D, Eton DT, Fairclough DL et al (2002) What is a clinically meaningful change on the Functional Assessment of Cancer Therapy–Lung (FACT-L) questionnaire?: results from Eastern Cooperative Oncology Group (ECOG) Study 5592. J Clin Epidemiol 55(3):285–295
Fiteni F, Anota A, Westeel V et al (2016) Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review. BMC Cancer 16(1):122
Singh-Manoux A, Adler NE, Marmot MG (2003) Subjective social status: its determinants and its association with measures of ill-health in the Whitehall II study. Soc Sci Med 56(6):1321–1333
All the participants provided written informed consent. The study was approved by the ethics committee of Shanghai Chest Hospital, Shanghai Jiao Tong University (No. KS1353).
Conflict of interest
The authors declare that they have no competing interests.
About this article
Cite this article
Chen, J.E., Lou, V.W., Jian, H. et al. Objective and subjective financial burden and its associations with health-related quality of life among lung cancer patients. Support Care Cancer 26, 1265–1272 (2018) doi:10.1007/s00520-017-3949-4
- Financial burden
- Quality of life
- Lung cancer
- Perceived financial difficulty
- Catastrophic health spending